Healthcare -
Biotechnology - NASDAQ - US
$ 1.545
5.82 %
$ 99.3 M
Market Cap
-1.0
P/E
INZY - OPERATING INCOME
Operating Income INZY - Inozyme Pharma, Inc.
-75.6 M
LAST VALUE
-15.56%
2 YEAR CAGR
-45.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR